Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sterkers

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Obstetrics and Gynecology|April 1, 1979
Benign breast disease I: hormonal investigationR Sitruk-Ware, N Sterkers, P Mauvais-Jarvis
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|April 1, 1978
[The treatment of benign pathological conditions of the breasts with progesterone and progestogens. The results according to the type of breast condition (260 case records) (author's transl)]P Mauvais-Jarvis, N Sterkers, F Kuttenn, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1977
Inadequate corpus luteal function in women with benign breast diseasesL R Sitruk-ware, N Sterkers, I Mowszowicz, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1975
[Hormonal function of the ovarian corpus luteum during benign mammary diseases]P Mauvais-Jarvis, A Tamborini, N Sterkers, et al.
Annales D'Endocrinologie|September 1, 1976
[Inadequate corpus luteum function in benign breast-diseases (author's transl)]P Mauvais-Jarvis, R Ware, N Sterkers, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 1, 1987
Prolactin secretion in benign breast diseasesR Sitruk-Ware, F Clair, N Sterkers, et al.
Cancer Research|June 1, 1985
Estradiol 17 beta-hydroxysteroid dehydrogenase, a marker of breast cancer hormone dependencyS Fournier, F Brihmat, J C Durand, et al.
Pathologie-Biologie|June 1, 1985
[Evaluation of 17-beta-hydroxysteroid dehydrogenase activity as a marker of the hormone dependence of breast cancers]S Fournier, F Allali, J C Durand, et al.
Breast (Edinburgh, Scotland)|December 30, 2016
Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypesJ Barrou, M Bannier, M Cohen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Obstetrics and Gynecology|April 1, 1979
Benign breast disease I: hormonal investigationR Sitruk-Ware, N Sterkers, P Mauvais-Jarvis
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|April 1, 1978
[The treatment of benign pathological conditions of the breasts with progesterone and progestogens. The results according to the type of breast condition (260 case records) (author's transl)]P Mauvais-Jarvis, N Sterkers, F Kuttenn, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1977
Inadequate corpus luteal function in women with benign breast diseasesL R Sitruk-ware, N Sterkers, I Mowszowicz, et al.
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|January 1, 1975
[Hormonal function of the ovarian corpus luteum during benign mammary diseases]P Mauvais-Jarvis, A Tamborini, N Sterkers, et al.
Annales D'Endocrinologie|September 1, 1976
[Inadequate corpus luteum function in benign breast-diseases (author's transl)]P Mauvais-Jarvis, R Ware, N Sterkers, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 1, 1987
Prolactin secretion in benign breast diseasesR Sitruk-Ware, F Clair, N Sterkers, et al.
Cancer Research|June 1, 1985
Estradiol 17 beta-hydroxysteroid dehydrogenase, a marker of breast cancer hormone dependencyS Fournier, F Brihmat, J C Durand, et al.
Pathologie-Biologie|June 1, 1985
[Evaluation of 17-beta-hydroxysteroid dehydrogenase activity as a marker of the hormone dependence of breast cancers]S Fournier, F Allali, J C Durand, et al.
Breast (Edinburgh, Scotland)|December 30, 2016
Pathological complete response in invasive breast cancer treated by skin sparing mastectomy and immediate reconstruction following neoadjuvant chemotherapy and radiation therapy: Comparison between immunohistochemical subtypesJ Barrou, M Bannier, M Cohen, et al.
Pageof 1